ArticleCureus2025
Dendritic Cell Neurofibroma With Pseudorosettes: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dendritic cell neurofibroma with pseudorosettes (DCNP) is an exceedingly rare neurofibroma variant presenting as scattered, isolated, skin-colored papules or nodules primarily on the trunk. It consists of clusters of smaller type I cells with dark nuclei and inconspicuous cytoplasm, surrounded by much larger type II cells with abundant cytoplasm and vesicular nuclei containing pseudoinclusions, resulting in the formation of distinctive pseudorosettes. While unique, it can be misdiagnosed as other neural tumors due to its histologic and clinical similarities. This report presents a unique case of DCNP in a 34-year-old male with a longstanding, asymptomatic 1.3 cm pink nodule on his mid-chest, initially suspected to be a neurofibroma. This case, along with surgical excision and histopathologic evaluation, provides valuable insight into the diagnosis of DCNP, highlighting the need for increased recognition of this rare entity and encouraging further research to refine diagnostic criteria and management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.